These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22029181)

  • 1. Alpha-1-Fetoprotein (AFP): international proficiency study with different test systems.
    Oremek GM; Oertl A; Bertsch T; Bewarder N; Bürger V; Dannenberg R; Dibbelt L; Gerstmeyer A; Grunow G; Irmer-Vorpeil A; Klapdor R; Klemm M; Krengel G; Lerahn A; Marivoet S; Misianik J; Ortin V; Peeters V; Röder B; Schauer I; Schneider A; Schweiger AM; Seefried D; Straetmans D; Trommer A; Weinhold A
    Clin Lab; 2011; 57(9-10):669-75. PubMed ID: 22029181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External quality control program for inter-laboratory quality control.
    Bewarder N; Müller P
    Anticancer Res; 2000; 20(6D):5213-6. PubMed ID: 11326697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
    Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Takahashi Y; Taguchi T
    J Pediatr Hematol Oncol; 2008 Jun; 30(6):447-50. PubMed ID: 18525461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of laboratory test volume and geographic location on maternal alpha-fetoprotein results. Information from the College of American Pathologists Maternal alpha-fetoprotein Survey.
    Eckfeldt JH; Long TA
    Arch Pathol Lab Med; 1991 Jul; 115(7):647-53. PubMed ID: 1712194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External quality control survey for alpha-fetoprotein assay.
    Zucchelli GC; Pilo A; Ferdeghini M; Chiesa MR; Masini A; Clerico A
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):30-3. PubMed ID: 2480418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the clinical use of alpha-fetoprotein (AFP) colloidal gold diagnostic strip].
    Jiang XM; Kong J; Lin T; Yu XY; Chen Y; Dai Y; Yang HY; Sun XL; Yang J; Yang YQ; Zhang YC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):210-2. PubMed ID: 12816714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
    Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedure for accurate evaluation of laboratory data and its international trends].
    Kuwa K
    Rinsho Byori; 2005 Jun; 53(6):531-9. PubMed ID: 16026081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of reagent lot-to-lot comparability tests in five immunoassay items.
    Kim HS; Kang HJ; Whang DH; Lee SG; Park MJ; Park JY; Lee KM
    Ann Clin Lab Sci; 2012; 42(2):165-73. PubMed ID: 22585613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of serum alpha-fetoprotein in dogs with hepatic tumors.
    Lowseth LA; Gillett NA; Chang IY; Muggenburg BA; Boecker BB
    J Am Vet Med Assoc; 1991 Sep; 199(6):735-41. PubMed ID: 1720115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an inexpensive and rapid two site microenzyme linked immunosorbent assay kit for human alpha fetoprotein.
    Bansal V; Kumari K; Sahib MK
    Indian J Exp Biol; 1989 Oct; 27(10):907-9. PubMed ID: 2483953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
    Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first clinical trial for determination of alpha 1 fetoprotein by means of Sevatest-ELISA AFP Kit (micro I).
    Mancal P; Srámek M; Malbohan I; Simek L
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):209-17. PubMed ID: 2457612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Definite diagnosis of premature rupture of the membranes (PROM) using intra-amniotic dye injection method and development of a new kit (AFP-test kit) for PROM diagnosis].
    Kishida T
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):913-26. PubMed ID: 7525438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assay for alpha-fetoprotein in human serum.
    Chui SH; Yow CM; Lam CW; Wan KC; Lewis WH
    Med Lab Sci; 1989 Oct; 46(4):305-8. PubMed ID: 2482399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T; Ellis A; Jones R
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories.
    Fritzler MJ; Wiik A; Tan EM; Smolen JS; McDougal JS; Chan EK; Gordon TP; Hardin JA; Kalden JR; Lahita RG; Maini RN; Reeves WH; Rothfield NF; Takasaki Y; Wilson M; Byrd MG; Slivka L; Koziol JA
    J Rheumatol; 2003 Nov; 30(11):2374-81. PubMed ID: 14677180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
    Lamerz R; Runge M; Stieber P; Meissner E
    Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European proficiency study with control serum for the tumor marker CA 19-9 measured on different test systems.
    Bertsch T; Aschenneller C; Bewarder N; Beyrau R; Herrmann BL; Jansen E; Klapdor R; Klemm M; Meissner J; Pfeiffer S; Schauer I; Stratmann MM; Theimer C; van de Loo HM; Wildbredt DA; Wolff C; Wollenberg P
    Clin Lab; 2013; 59(1-2):185-92. PubMed ID: 23505925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.